Skip to main content

Table 1 Patient characteristics

From: Comparison of machine learning models and CEUS LI-RADS in differentiation of hepatic carcinoma and liver metastases in patients at risk of both hepatitis and extrahepatic malignancy

Parameter

All data

Training Cohort

Validation Cohort

HCC(N = 2811)

LM(N = 399)

P

HCC(N = 183)

LM(N = 183)

P

HCC(N = 44)

LM(N = 44)

P

Age

57.39 ± 11.39

58.79 ± 10.61

0.020

57.26 ± 11.16

59.15 ± 9.67

0.083

61.52 ± 10.84

59.75 ± 11.27

0.454

Diameter

4.99 ± 3.32

4.43 ± 2.81

0.001

5.36 ± 11.93

5.15 ± 4.82

0.821

4.97 ± 4.23

5.03 ± 5.82

0.954

Sex

  

< 0.001

  

0.348

  

0.280

Female

504 (17.93%)

154 (38.60%)

 

46 (25.14%)

54 (29.51%)

 

16 (36.36%)

21 (47.73%)

 

Male

2307 (82.07%)

245 (61.40%)

 

137 (74.86%)

129 (70.49%)

 

28 (63.64%)

23 (52.27%)

 

Jaundice

  

0.096

  

0.410

  

0.148

No

2737 (97.37%)

394 (98.75%)

 

179 (97.81%)

181 (98.91%)

 

41 (95.35%)

44 (100.00%)

 

Yes

74 (2.63%)

5 (1.25%)

 

4 (2.19%)

2 (1.09%)

 

2 (4.65%)

0 (0.00%)

 

Abdomen pain

  

0.001

  

0.068

  

0.141

No

2354 (83.74%)

308 (77.19%)

 

153 (83.61%)

139 (75.96%)

 

36 (83.72%)

31 (70.45%)

 

Yes

457 (16.26%)

91 (22.81%)

 

30 (16.39%)

44 (24.04%)

 

7 (16.28%)

13 (29.55%)

 

Vascular invasion

  

0.010

  

0.091

  

0.091

No

2572 (91.50%)

380 (95.24%)

 

167 (91.26%)

175 (95.63%)

 

39 (88.64%)

43 (97.73%)

 

Yes

239 (8.50%)

19 (4.76%)

 

16 (8.74%)

8 (4.37%)

 

5 (11.36%)

1 (2.27%)

 

Multiple tumors

  

0.993

  

0.224

  

0.080

No

2262 (80.47%)

321 (80.45%)

 

154 (84.15%)

145 (79.23%)

 

40 (90.91%)

41 (93.18%)

 

Yes

549 (19.53%)

78 (19.55%)

 

29 (15.85%)

38 (20.77%)

 

4 (9.09%)

3 (6.82%)

 

Extrahepatic tumor

  

< 0.001

  

NA

  

NA

No

2691 (95.73%)

7 (1.75%)

 

183 (100%)

0 (0.00%)

 

0 (0.00%)

0 (0.00%)

 

Yes

120 (4.27%)

392 (98.25%)

 

0 (0.00%)

183 (100%)

 

44 (100.00%)

44 (100.00%)

 

Chronic hepatitis B

  

0.706

  

NA

  

NA

No

0 (0.00%)

0 (0.00%)

 

0 (0.00%)

0 (0.00%)

 

0 (0.00%)

0 (0.00%)

 

Yes

2811(100%)

399 (100%)

 

183 (100%)

183 (100%)

 

44 (100.00%)

44 (100.00%)

 
  1. LM: Liver metastasis; HCC: Hepatocellular carcinoma; NA: Not available